The full impact these medications will have on retail returns remains to be seen
Lets dive into why insurance coverage for GLP-1 medications is so limited, and what this means for the future of obesity treatment and health care costs
Semaglutide or Tirzepatide Starter Doses cannot be prescribed or purchased by individuals with a BMI under 26, Gastroparesis (Paralysis of your intestines), Triglycerides over 600 at any point, Pancreatic cancer, Pancreatitis, Type 1 diabetes, Hypoglycemia (low blood sugar), Insulin-dependent diabetes, Thyroid cancer, Family history of thyroid cancer, Personal or family history of Multiple Endocrine Neoplasia (MEN-2) syndrome, Anorexia or bulimia, Current symptomatic gallstones, Drug or alcohol abuse, Recent bariatric surgery, Diabetic retinopathy
For step-by-step reconstitution instructions, see the BPC-157 reconstitution guide same general technique applies
Cells were subsequently mounted with PermaFluor and visualized using an inverted fluorescence microscope (Nikon Eclipse Ti) at 20 or 40 magnification
It is important because it provides human biomarker-level support for the idea that GLP-1RA therapy influences redox-related physiology in parallel with its metabolic actions